Tomoyuki Akiyama
Overview
Explore the profile of Tomoyuki Akiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
1434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagata T, Shibata T, Tsuchiya H, Akiyama M, Kato M, Akiyama T, et al.
Am J Med Genet A
. 2025 Feb;
:e64030.
PMID: 39996381
No abstract available.
2.
Nishikage S, Yamamoto M, Niikura T, Inaba Y, Akiyama T, Harada R, et al.
Endocr J
. 2025 Jan;
PMID: 39880615
The use of asfotase alfa, a bone-targeted recombinant alkaline phosphatase (ALP) enzyme, for the treatment of adult-onset hypophosphatasia (HPP) remains controversial, particularly in patients without evident bone abnormalities. We report...
3.
Yoshida H, Murakami T, Ogawa A, Sunouchi T, Hidaka N, Ito N, et al.
Endocrinol Diabetes Metab Case Rep
. 2025 Jan;
2025(1).
PMID: 39868560
Summary: Hypophosphatasia (HPP) is a genetic disorder due to pathological variants in ALPL, the gene encoding tissue-nonspecific alkaline phosphatase (ALP). HPP is typically associated with bone-related symptoms, such as bone...
4.
Kobayashi K, Shibata T, Tsuchiya H, Akiyama M, Akiyama T
Brain Dev
. 2025 Jan;
47(1):104318.
PMID: 39787996
Introduction: Epileptic encephalopathy (EE) is a serious clinical issue that manifests as part of developmental and epileptic encephalopathy (DEE), particularly in childhood epilepsy. In EE, neurocognitive functions and behavior are...
5.
Kikuchi K, Kuki I, Nishiyama M, Ueda Y, Matsuura R, Shiohama T, et al.
Brain Dev
. 2024 Dec;
47(1):104306.
PMID: 39626562
The updated definition of status epilepticus (SE) by the International League Against Epilepsy in 2015 included two critical time points (t: at which the seizure should be regarded as an...
6.
Tsuchiya H, Shibata T, Sasaki T, Akiyama M, Akiyama T, Kobayashi K
Brain Dev
. 2024 Sep;
46(10):339-343.
PMID: 39304424
Introduction: Post-operative complications of corpus callosotomy (CC) in children, prolonged hospitalization due to inactivity as acute disconnection syndrome is occasionally experienced. We aimed to clarify this issue and its risk...
7.
Tamefusa K, Ishida H, Miyahara D, Shiwaku T, Ochi M, Kanamitsu K, et al.
Ann Hematol
. 2024 Sep;
103(11):4805-4809.
PMID: 39287655
Pediatric ALK-positive anaplastic large cell lymphoma is a rare subtype of non-Hodgkin lymphoma, and approximately 30% of patients relapse following treatment with conventional chemotherapy. Alectinib monotherapy has demonstrated excellent activity...
8.
Shibata T, Tsuchiya H, Akiyama M, Akiyama T, Kobayashi K
Epilepsy Res
. 2024 Apr;
202:107359.
PMID: 38582072
Purpose: In developmental and epileptic encephalopathy with spike-and-wave activation in sleep (DEE-SWAS), the thalamocortical network is suggested to play an important role in the pathophysiology of the progression from focal...
9.
Oto Y, Suzuki D, Morita T, Inoue T, Nitta A, Murakami N, et al.
J Pediatr Endocrinol Metab
. 2024 Feb;
37(3):276-279.
PMID: 38310522
Objectives: Hypophosphatasia (HPP) is a rare skeletal dysplasia caused by variants in the () gene. More than 400 pathogenic variants of the gene have been registered in the ALPL gene...
10.
Akiyama T, Saigusa D, Inoue T, Tokorodani C, Akiyama M, Michiue R, et al.
Brain Dev
. 2024 Jan;
46(4):180-186.
PMID: 38171994
Objective: The discovery of objective indicators for recent epileptic seizures will help confirm the diagnosis of epilepsy and evaluate therapeutic effects. Past studies had shortcomings such as the inclusion of...